Analysts polled by FactSet expected much higher deliveries of 408,000. Dan Ives of Wedbush said in a note to clients that ...

There are no winners when it comes to President Donald Trump ’s tariffs on car imports, according to Wedbush Securities Inc. analyst Daniel Ives, who described the levies as a “back breaker and ...

(Bloomberg) -- There are no winners when it comes to President Donald Trump’s tariffs on car imports, according to Wedbush Securities Inc. analyst Daniel Ives, who described the levies as a ...

After speaking to auto industry experts from the U.S., Europe, and Asia, Wedbush concluded President Trump’s 25% tariff on all cars and parts made outside the U.S. “would send the auto ...

In a note, the Wedbush Securities analyst said: “Let’s call it like it is: Tesla is going through a crisis and there is one person who can fix it … Musk.” A protester stands outside a ...

Investing.com -- The negative investor sentiment around Microsoft (NASDAQ:MSFT) stock is “way overdone” and 2025 is expected to be an inflection point of growth for the tech giant, according to ...

Andrew Harnik via Getty Images Long-time Tesla bull Dan Ives, an analyst at Wedbush Securities, says Elon Musk is the only one who can turn the EV maker's reputation around and the billionaire ...

Wedbush analyst Dan Ives sharpened his criticism of how Elon Musk is running Tesla Inc., saying the electric-vehicle giant’s chief executive needs to make two major moves to stop the stock’s ...

Wedbush Securities analyst Dan Ives has consistently been bullish on Tesla. But Ives said the company is in a "crisis" that only Elon Musk can solve. Ives wrote in a Wednesday memo that Musk needs ...

In a report released today, David Nierengarten from Wedbush maintained a Buy rating on Immunome (IMNM – Research Report), with a price target of $33.00. The company’s shares closed yesterday ...